维普中文期刊产品整合服务
239篇 您的检索式:作者名="Geusens"
    题名 作者 年代 出处 被引量
1Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis显示文摘van Staa T P Geusens P Bijlsma W J 2006Arthritis Rheum2006,54,:1
2Long-term follow-up after interbody fusion of the cervical spine显示文摘Goffin J Geusens E Vantomme N 0,,02:1
3Strategies for treatment to prevent fragility fractures inpostmenopausal women 显示文摘Geusens P 2009Best Pract Resclin Rheumatol2009,23,6:1
4Efficacy and safety of infliximab in patients with ankylosing spondylitis re- sults of a randomized, placebo - controlled trial(ASSERT) 显示文摘Vander Heijde D Dijkmans B Geusens P 2005Arthritis Rheum2005,52,2:1
5Long-term follow-up after inter-body fusion of the cervical spine显示文摘Goffin J Geusens E Vantomme N 2004J Spinal Disord Tech2004,17,:1
6Osteoporosis, frailty and fracture:implications for case finding and therapy显示文摘van den Bergh JP van Geel TA Geusens PP 2012Nat Rev Rheumatol2012,8,3:1
7Risk factors for osteoporosis related to their outcome: Fractures 显示文摘Van der Voort D J Geusens PP Dinant GJ 2001Osteoporos Int2001,12,8:1
8Adherence and profile of non-persistence in patients treated for osteoporosis--a large-scale,long-term retrospective study in The Netherlands显示文摘Netelenbos JC Geusens PP Ypma G 2010Osteoporos Int2010,22,5:1
9Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture 显示文摘Bours S P van Gee1 T A Geusens P P 2011J Clin Endocrinol Metab2011,96,5:1
10Long-term followup after interbody fusion of the cervical spine显示文摘Goffin J Geusens E Vantomme N 2004J Spinal Disord Tech2004,17,2:1
11Efficacy and safety of infliximab in patients with ankylosing spondylitis:results of a randomized,placebo-controlled trial(ASSERT)显示文摘Van DH Dijkmans B Geusens P 0,,02:1
12Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis:a 12-month,double-blind,controlled study显示文摘Geusens P Wouters C Nijs J 0,,06:1
13Vitanim K1 supple-mentation retards bone loss in postmenopausaul women between 50 and 60 years of age显示文摘Braam LA Knapen MH Geusens P 2008Caleif Tissue Int2008,73,:1
14The role of RANK ligand/osteoprotegerin in rheumatoid arthritis显示文摘Geusens P 2012Ther Adv Musculoskelet Dis2012,4,4:1
15Development of a 3Dpigmented skin model to evaluate RNAi-induced depigmentation 显示文摘Van Gele M Geusens B Speeckaert R 2011Exp Dermatol2011,20,9:1
16Contributors to sec- ondary osteoporosis and metabolic bone diseases in patients pxsen- ting wi|h a clinical fiactnre显示文摘Bours SP van Geel TA Geusens PP 2011J Clin Endocrinol Melab2011,96,5:1
17term follow - up after interbody fusion cervical spine 显示文摘Goffin Long - of the Teeh J Geusens E Vantomme N 2004Spinal Disord2004,17,:1
18Musculoskeletal rehabilitation in osteoporosis:a review显示文摘Pfeifer M Sinaki M Geusens P 0,,08:1
19Long-term follow-up after interbody fusion of cervical spine显示文摘Goffin J Geusens E Vantomme N 2004J Spinal Disord Tech2004,17,2:1
20Effica- cy and safety of infliximab in patients with ankylosing spon- dylitis : results of randomized, placebo- controlled trial ( AS- SERT) 显示文摘van der HEIJDE D DIJKMANS B GEUSENS P 2005Arthritis Rheum2005,52,:1
返回顶部 每页显示:
共12页 首页 上一页 第1页 下一页 末页 /12 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费